Table 3.
Summary of renal clearance (CLR) and apparent total plasma clearance (CL/F) of edoxaban, presented by renal function [17]
| Parameter | Normal: CLCR >80 mL/min; N = 8 | Mild impairment: CLCR ≥50–≤80 mL/min; N = 8 | Moderate impairment: CLCR ≥30–<50 mL/min; N = 8 | Severe impairment: CLCR <30 mL/min; N = 8 |
|---|---|---|---|---|
| C max (ng/mL) | 84.7 ± 26.4 | 113 ± 48.9 | 115 ± 42.3 | 91.9 ± 32.8 |
| AUC∞ (ng·h/mL) | 453 ± 102 | 636 ± 152 | 816 ± 209 | 857 ± 199 |
| CLR (L/h) | 11.9 ± 1.88 | 7.68 ± 2.57 | 4.30 ± 1.72 | 2.12 ± 0.88 |
| CL/F (L/h) | 34.6 ± 7.32 | 24.8 ± 6.00 | 19.4 ± 4.69 | 18.5 ± 4.87 |
Data are presented as mean ± standard deviation
AUC ∞ area under the concentration–time curve extrapolated from time zero to infinity, CL CR creatinine clearance, C max maximum observed plasma drug concentration